Boehringer Ingelheim at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Boehringer Ingelheim takes part in 7 sessions at ACT 2026 in San Antonio. Its program centres on first-in-human dose selection and on AI and new approach methods for predicting liver toxicity. Concrete topics include agentic AI in toxicology, a cross-platform project testing lab-grown liver models for drug-induced liver injury, and career routes into pharma toxicology.

Organization

ACT 2026 Attendance

Boehringer Ingelheim

Ingelheim, Germany

boehringer-ingelheim.com

Pharmaceutical companies

Family-owned German pharmaceutical company developing human medicines and animal health products.

Session

Sun Nov 15
8:00am–11:30am

First-in-Human Dose Selection: Translational Strategies and Special Considerations across Modalities and Organ Systems (CE1)

Translational safety · with Novartis

8:00amFoundational Approaches to FIH Dose Selection (CE1-1)White Oak Regulatory Tox
8:20amModel-Informed Approaches to FIH Dose Prediction (CE1-2)Bedard ADME-Tox Solutions, Tango Therapeutics
8:45amCNS-Delivered Therapeutics: Anatomic, Physiologic, and Modality-Specific Considerations (CE1-3)Akkeri
9:10amInter-Species Dose Extrapolation for Ocular Therapeutics: Translational Frameworks for Eye-Delivered Products (CE1-4)Novartis
10:00amCrossing the Species Divide in Inhaled Dosing (CE1-5)Novartis
10:25amInteractive Session: Hypothetical Challenge Scenarios in FIH Setting (CE1-6)Boehringer Ingelheim

Session

Sun Nov 15
8:00am–11:30am

From Predictive Models to Collaborative Intelligence: The Role of Agentic AI in the Future of Toxicology (CE2)

In silico and AI · with Human Chemical

8:00amWelcome and Course Overview (CE2-1)Human Chemical
8:05amAgentic AI 101: A Primer for Drug Discovery and Development Toxicologists (CE2-2)Taiho Oncology
8:30amAgentic AI Frameworks for Predictive Toxicology-Based Literature Searches (CE2-3)Coincidence Labs
9:00amSynthesizing Experimental Results and In-Silico Predictions for Autonomous Hypothesis Generation (CE2-4)Human Chemical
10:00amLeveraging Agentic AI to Reassess and Optimize Previously Failed Compounds (CE2-5)Ignota Labs
10:30amChemistry Foundation Models for Optimal Drug Design (CE2-6)deepmirror

Talk

Sun Nov 15
10:25am–11:30am

Part of First-in-Human Dose Selection: Translational Strategies and Special Considerations across Modalities and Organ Systems (CE1)

Interactive Session: Hypothetical Challenge Scenarios in FIH Setting (CE1-6)

Translational safety

Poster

Mon Nov 16
5:00pm–6:30pm

IL-10–Associated Thrombocytopenia Is Not Mediated by Direct Platelet Effects (P129)

Nelson Exhibit Ballroom · Poster P129

Immunotoxicology · Pathology

Poster

Mon Nov 16
5:00pm–6:30pm

Strengthening Regulatory Confidence in Liver MPS: Insights from The 3Rs Collaborative’s & FDA CDER’s Cross Platform DILI Project (P213)

Nelson Exhibit Ballroom · Poster P213

New approach methods · Regulatory

Session

Tue Nov 17
9:00am–12:00pm

Next-Generation Liver Toxicity Assessment: Integrating Human-Relevant NAMs, AI, and Exposure Modeling (S07)

New approach methods · In silico and AI · with Physicians Committee for Responsible Medicine

9:00amIntroduction (S07-1)Physicians Committee for Responsible Medicine
9:05amAn Integrated NAM Platform Combining Bioactivity Prediction with PBPK and Literature Intelligence for Chemical Liver Toxicity Assessment (S07-2)Human Chemical
9:30amMulticellular Hepatic In Vitro Models Using NANOSTACKS™: Flow-Driven Differential Toxicity and Human-Relevant Drug Response Prediction (S07-3)Revivocell
9:55amAI-Enabled, Exposure-Anchored DILI Prediction Using Human 3D Liver Microtissues (S07-4)InSphero
10:45amFrom Exposure Dynamics to Uncertainty: A Hybrid Framework for Drug-Induced Liver Injury Prediction (S07-5)ESQlabs
11:25amNovel Optical Techniques to Study Hepatic Microplastic Pollution: Optical Imaging as a Powerful New Approach Methodology (S07-6)University of New Mexico

Talk

Wed Nov 18
2:00pm–2:20pm

Part of The Versatile Toxicologist: How to Leverage Expertise into Opportunity (S16)

Conventional and Unconventional Trajectories to a Toxicologist Career in the Pharmaceutical Sector (S16-1)

Careers

Instantly find 20 buyers from Boehringer Ingelheim

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction